LBX PHARMACY CHAIN JSC operates in the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares LBX PHARMACY CHAIN JSC with three other
companies in this sector in CHINA :
Yifeng Pharmacy Chain Co Ltd
sales of 10.28 billion Chinese Renmimbi [US$1.48 billion]
of which 93%
was Medicine Retail),
Yixintang Pharmaceutical Group Co Ltd
(10.48 billion Chinese Renmimbi [US$1.51 billion]
of which 95%
was Retail Sale), and
Dashenlin Pharmaceutical Group Co Ltd
(11.14 billion Chinese Renmimbi [US$1.61 billion]
of which 125%
was South China).
LBX PHARMACY CHAIN JSC reported sales of 11.66 billion Chinese Renmimbi (US$1.68 billion)
December of 2019.
increase of 23.1%
versus 2018, when the company's sales were 9.47 billion Chinese Renmimbi.
Sales at LBX PHARMACY CHAIN JSC have increased during each of the previous five years
(and since 2014, sales have increased a total of 196%).
Sales of Pharmaceutical Wholesale saw an increase
33.6% in 2019, from
965.37 million Chinese Renmimbi to 1.29 billion Chinese Renmimbi.